Revalia Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 11

Revalia Bio General Information

Description

Developer of a human biology data platform designed to support drug and medical device development using donated organs and tissues. The company's platform generates multimodal datasets from donated human organs and tissues, captures real-time physiological measurements and molecular information across multiple biological scales, integrates human-derived datasets, and applies artificial intelligence foundation models to interpret complex biological data, enabling pharmaceutical and medical device developers to use human-derived evidence to guide research and development decisions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 55 Church Street
  • Suite 400
  • New Haven, CT 06510
  • United States
+1 (312)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 55 Church Street
  • Suite 400
  • New Haven, CT 06510
  • United States
+1 (312)

Revalia Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revalia Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 04-Sep-2025 $14.5M Completed Generating Revenue
2. Seed Round 29-Oct-2024 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Revalia Bio’s complete valuation and funding history, request access »

Revalia Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed-4
Seed-3 424,906 $0.000100 8% $6.66 $6.66 1x $6.66 10.95%
Seed-2 90,086 $0.000100 8% $2.22 $2.22 1x $2.22 2.32%
To view Revalia Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Revalia Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revalia Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
America's Frontier Fund Venture Capital Minority
Pamir Ventures Venture Capital Minority
Angel (individual) Minority
Sierra Ventures Venture Capital Minority
BoxOne Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Revalia Bio FAQs

  • When was Revalia Bio founded?

    Revalia Bio was founded in 2021.

  • Where is Revalia Bio headquartered?

    Revalia Bio is headquartered in New Haven, CT.

  • What is the size of Revalia Bio?

    Revalia Bio has 38 total employees.

  • What industry is Revalia Bio in?

    Revalia Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Revalia Bio a private or public company?

    Revalia Bio is a Private company.

  • What is Revalia Bio’s current revenue?

    The current revenue for Revalia Bio is .

  • How much funding has Revalia Bio raised over time?

    Revalia Bio has raised $26.8M.

  • Who are Revalia Bio’s investors?

    America's Frontier Fund, Pamir Ventures, , Sierra Ventures, and BoxOne Ventures are 5 of 11 investors who have invested in Revalia Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process